Shi, Lewis Zhichang
Fu, Tihui
Guan, Baoxiang
Chen, Jianfeng
Blando, Jorge M.
Allison, James P.
Xiong, Liangwen
Subudhi, Sumit K.
Gao, Jianjun
Sharma, Padmanee
Article History
Received: 19 February 2016
Accepted: 23 June 2016
First Online: 8 August 2016
Competing interests
: Drs Sharma and Allison are founders of Jounce Therapeutics. Dr Sharma also serves as a consultant for Bristol-Myers Squibb (BMS), Amgen and Glaxo SmithKline. Dr Allison is an inventor of intellectual property owned by the UC-Berkeley, and licensed to BMS and has received royalties from BMS. Dr Allison is also inventor of intellectual property owned by Memorial-Sloan Kettering Cancer Center and licensed to Merck. All other authors have no conflict of interest to disclose.